MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > REALITY CHECK FOR MEDMIRA MANAGEMENT

<< Previous

Bullboard Posts

Next >>

Comment by goldyhawkon Apr 08, 2024 9:19am

83 Views

Post# 35976424

RE:RE:RE:RE:REALITY CHECK FOR MEDMIRA MANAGEMENT

ONE thing I know for sure is that how little or how much I know or don’t know about the company WILL NOT MAKE ANY DIFFERENCE IN MEDMIRA ‘s SUCCESS OR FAILURE

BUT

With the lack of some clarity it is a challenge to believe what Medmira is suggesting - such as some or all of the following —-

no profit for first half calendar yr 2024

then

some profit second half calendar yr 2024

AND THEN

sometime in 2025
dividends or buyout

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant